Atomistic Simulation To Understand Anisotropic Growth Behavior of Naproxen Crystal in the Presence of Polymeric Additives
暂无分享,去创建一个
[1] R. Davey,et al. The Kinetic Story of Tailor-made Additives in Polymorphic Systems: New Data and Molecular Insights for p-Aminobenzoic Acid , 2018, Crystal Growth & Design.
[2] R. Tan,et al. Effect of API-Polymer Miscibility and Interaction on the Stabilization of Amorphous Solid Dispersion: A Molecular Simulation Study , 2017 .
[3] V. D. Chia,et al. Anisotropic Crystal Growth Inhibition by Polymeric Additives: Impact on Modulation of Naproxen Crystal Shape and Size , 2017 .
[4] K. Roberts,et al. Influence of Solvent Composition on the Crystal Morphology and Structure of p-Aminobenzoic Acid Crystallized from Mixed Ethanol and Nitromethane Solutions , 2017 .
[5] Z. Nagy,et al. A study on the effect of the polymeric additive HPMC on morphology and polymorphism of ortho-aminobenzoic acid crystals , 2016 .
[6] Zoltan K. Nagy,et al. Tuning Crystal Morphology of Succinic Acid Using a Polymer Additive , 2016 .
[7] R. Tan,et al. Pore size effect on the stabilization of amorphous drug in a mesoporous material: Insights from molecular simulation , 2016 .
[8] R. Tan,et al. Crystallizing Micronized Particles of a Poorly Water-Soluble Active Pharmaceutical Ingredient: Nucleation Enhancement by Polymeric Additives , 2016 .
[9] K. Olsen,et al. Drug-polymer interactions at water-crystal interfaces and implications for crystallization inhibition: molecular dynamics simulations of amphiphilic block copolymer interactions with tolazamide crystals. , 2015, Journal of pharmaceutical sciences.
[10] Haitao Li,et al. An Integrated Process Analytical Technology (PAT) Approach for Pharmaceutical Crystallization Process Understanding to Ensure Product Quality and Safety: FDA Scientist’s Perspective , 2015 .
[11] Michael A. Lovette,et al. Needle-Shaped Crystals: Causality and Solvent Selection Guidance Based on Periodic Bond Chains , 2013 .
[12] Gautam R Desiraju,et al. Crystal engineering: from molecule to crystal. , 2013, Journal of the American Chemical Society.
[13] Xinggui Zhou,et al. Impurity Effect of l-Valine on l-Alanine Crystal Growth , 2013 .
[14] Francis S. Romanski,et al. Atomistic simulations of aqueous griseofulvin crystals in the presence of individual and multiple additives , 2012 .
[15] R. Tan,et al. Molecular simulation study of the effect of various additives on salbutamol sulfate crystal habit. , 2011, Molecular pharmaceutics.
[16] Francis S. Romanski,et al. Atomistic simulation study of surfactant and polymer interactions on the surface of a fenofibrate crystal. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[17] R. Tan,et al. The Effect and Counter-Effect of Impurities on Crystallization of an Agrochemical Active Ingredient: Stereochemical Rationalization and Nanoscale Crystal Growth Visualization , 2011 .
[18] R. Tan,et al. Direct Precipitation of Micron-Size Salbutamol Sulfate: New Insights into the Action of Surfactants and Polymeric Additives , 2010 .
[19] L. S. Taylor,et al. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation. , 2010, Molecular pharmaceutics.
[20] K. Roberts,et al. An Examination of the Influence of Divalent Cationic Dopants on the Bulk and Surface Properties of Ba(NO3)2 Associated with Crystallization , 2009 .
[21] S. Piana,et al. Aspartic acid as a crystal growth catalyst , 2007 .
[22] R. Tan,et al. Molecular Speciation Controlling Stereoselectivity of Additives: Impact on the Habit Modification in α-Glycine Crystals , 2007 .
[23] S. Piana,et al. Assisted desolvation as a key kinetic step for crystal growth. , 2006, Journal of the American Chemical Society.
[24] A. Sokolov,et al. Coupling between lysozyme and glycerol dynamics: microscopic insights from molecular-dynamics simulations. , 2005, The Journal of chemical physics.
[25] I. Weissbuch,et al. Toward Stereochemical Control, Monitoring, and Understanding of Crystal Nucleation , 2003 .
[26] P. Rodger,et al. Modelling the interaction between the poly(octadecyl acrylate) inhibitor and an n-octacosane crystal , 2000 .
[27] H. Sun,et al. COMPASS: An ab Initio Force-Field Optimized for Condensed-Phase ApplicationsOverview with Details on Alkane and Benzene Compounds , 1998 .
[28] R. Docherty,et al. Polymorphism in Molecular Crystals: Stabilization of a Metastable Form by Conformational Mimicry , 1997 .
[29] K. Sangwal. Effects of impurities on crystal growth processes , 1996 .
[30] M. Spring,et al. STUDIES ON PARACETAMOL CRYSTALS PRODUCED BY GROWTH IN AQUEOUS SOLUTIONS , 1994 .
[31] L. Addadi,et al. Control of polymorphism by ‘tailor‐made’ polymeric crystallization auxiliaries. Preferential precipitation of a metastable polar form for second harmonic generation , 1990 .
[32] L. Addadi,et al. Design of polymeric inhibitors for the control of crystal polymorphism. Induced enantiomeric resolution at racemic histidine by crystallization at 25.degree.C , 1987 .
[33] M. Idelson,et al. Crystal morphology engineering by "tailor-made" inhibitors; a new probe to fine intermolecular interactions , 1985 .